Dudediligence.

Oruka Therapeutics, Inc

ORKANASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 28424B5Prospectus for an offering
  2. Aug 248-KOfficer or director change5.029.01
  3. Aug 21S-3Shelf registration
  4. Aug 1413GPassive stake of 5% or more (13G), filed by Rtw Investments
  5. Aug 1213GPassive stake of 5% or more (13G), filed by Capital World Investors
  6. Aug 1010-QQuarterly report
  7. Aug 108-KResults of operations2.029.01
  8. Jun 48-KShareholder vote5.07
  9. Jun 18-KOther events8.019.01
  10. May 1310-QQuarterly report
  11. Apr 308-KResults of operations and other events2.028.019.01
  12. Apr 29424B5Prospectus for an offering
  13. Apr 27424B5Prospectus for an offering
  14. Apr 27424B5Prospectus for an offering
  15. Apr 278-KRegulation FD disclosure and other events7.018.019.01
  16. Apr 2S-3Shelf registration
  17. Mar 1210-KAnnual report
  18. Dec 11, 20258-KOfficer or director change5.029.01
  19. Nov 12, 202510-QQuarterly report
  20. Nov 5, 2025424B3Prospectus for an offering
  21. Nov 5, 2025424B5Prospectus for an offering
  22. Oct 3, 2025S-3Shelf registration
  23. Oct 3, 2025S-3Shelf registration
  24. Sep 22, 2025424B3Prospectus for an offering
  25. Sep 22, 20258-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  26. Aug 11, 2025424B3Prospectus for an offering
  27. Aug 11, 202510-QQuarterly report
  28. Jul 1, 20258-KOfficer or director change5.029.01